7,376.86

+23.13

+0.31%

51,285.73

-237.33

-0.46%

24,579.42

+264.43

+1.09%

2,754.11

+24.22

+0.89%

4.8590

+0.0220

+0.45%

25.64

-2.54

-9.01%

4,079.50

-34.00

-0.83%

75,817.19

+232.28

+0.31%

Crude Oil Dec 26

90.34

-0.18

-0.20%

US Private Equity

10,760.93

-143.81

-1.32%

NasdaqCM - Delayed Quote USD

Vicore Pharma Holding AB (publ) (VCRE)

10.40 +0.39 (+3.90%)

At close: 4:00:00 PM EST

Nike downgraded, Circle Internet upgraded: Wall Street's top analyst calls

The Fly 1d ago

RCL

RBLX

PK
Vicore Pharma Announces Third Quarter 2026 Financial Results and Provides Business Update

ACCESS Newswire 1d ago

VCRE
+8.90%
Vicore Announces the Nomination Committee for the 2027 Annual General Meeting

ACCESS Newswire 3d ago

VCRE
+8.90%
HBMN.SW
Vicore Pharma to Participate in the Guggenheim Annual Healthcare Innovation Conference and the Stifel Healthcare Conference

ACCESS Newswire 4d ago

VCRE
+8.90%
Vicore's Phase 2b ASPIRE Trial of Buloxibutid in IPF Passes Pre-Planned Futility Analysis and Remains on Track for Mid-2027 Topline Results

ACCESS Newswire 15d ago

VCRE
+8.90%
Vicore Pharma to Participate in the Chardan Healthcare Conference

ACCESS Newswire 24d ago

VCRE
+8.90%
Vicore Pharma to Present in The Stifel 2026 Virtual Immunology and Inflammation Forum

ACCESS Newswire 1mo ago

VCRE
+8.90%
SF
Vicore Pharma to Participate in Upcoming Healthcare Conferences

ACCESS Newswire 2mo ago

VCRE
+8.90%
VICO
Increase in Number of Shares and Votes in Vicore Pharma

ACCESS Newswire 1mo ago

VCRE
+8.90%
Vicore Pharma to Participate in the Leerink Therapeutics Forum

ACCESS Newswire 3mo ago

VICO.ST

VCRE
+8.90%

Mobilize your Website

View Site in Mobile | Classic

Share by: